自体输血设备市场概览、增长、趋势、分析、研究报告(2021-2028 年)

  • Report Code : TIPRE00006521
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 178
Buy Now

Autotransfusion Devices Market Size, Share | Analysis - 2028

Buy Now

 

自体输血设备市场预计将从 2021 年的 10.0026 亿美元增长到 2028 年的 13.3199 亿美元;预计 2021 年至 2028 年的复合年增长率为 4.2%。

器官移植是器官衰竭时进行的外科手术。通常,器官移植针对的是心脏、肝脏和肾脏等器官;然而,随着慢性病病例的增加,其他器官如肺、胰腺、角膜和血管组织也需要移植。这些过程通常需要数小时,而且会大量失血,而自体输血是防止失血的有效方法之一。根据器官共享联合网络(UNOS)的数据,美国进行的器官移植数量持续增加,2021 年进行了超过 41,000 例移植。同样,根据世界移植登记处的数据,西班牙在 2019 年占欧盟所有器官捐赠的 20%,占全球捐赠的 6%。澳大利亚的器官捐赠率近年来有所提高,2019 年上升至每百万人口 21.8 名捐赠者。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

自体输血设备市场:

自体输血设备市场
  • Autotransfusion Devices Market
    复合年增长率(2021 - 2028 年)
    4.2%
  • 2021 年市场规模
    10 亿美元
  • 2028 年市场规模
    13.3 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • 美敦力
  • 费森尤斯集团
  • 泰利福公司
  • 屋宇署
  • 齐默邦美
  • 布莱尔生物医药公司
  • 血液透析公司
  • SARSTEDT 股份公司和两合公司
  • LivaNova PLC

区域概况

Autotransfusion Devices Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Autotransfusion Devices Market类型
  • 产品和配件
Autotransfusion Devices Market应用
  • 心脏手术
  • 骨科手术
  • 器官移植
  • 创伤手术
  • 其他的
Autotransfusion Devices Market最终用户
  • 医院
  • 专科诊所
  • 门诊手术中心
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

同样,加拿大每百万人口有 22.2 名器官捐献者,并且还在稳步提高,这部分归功于“器官捐献医生”的数量——负责器官捐献的重症监护医生。根据世界移植登记处的数据,2019 年中国有 5,818 名器官捐献者,即每百万人口 4.1 名器官捐献者,印度有 715 名器官捐献者,即每百万人口 0.5 名器官捐献者。另一方面,俄罗斯的器官捐献者比例略高,为每百万人口 5.1 名器官捐献者。与移植协调员合作的公私伙伴关系为器官移植的改善做出了重大贡献。发展中国家和发达国家的器官移植手术都有所增加。例如,印度和新加坡等发展中国家正在成为亚太地区的医疗旅游目的地。各国在提供更好、更先进的医疗服务方面正在取得进步。因此,器官移植需求的增加是推动自体输血设备等移植诊断需求的关键因素之一。

自体输血过程涉及重新输注患者的血液。血液从腹腔或胸腔区域采集。该过程可以在手术前或手术期间和手术后使用自体输血系统进行。关节置换、脊柱手术和心脏手术等医疗程序都需要自体输血。它有助于降低感染风险,还可以消除与同源供血储存和管理相关的问题和并发症。它有助于防止患者传播与输血有关的血液传播疾病。

市场洞察
自体输血设备的技术发展

自体输血设备通常用于长时间手术(例如肾移植)和紧急情况。这些手术可能会出现失血过多,因此很难用新鲜血液弥补失血,尤其是在稀有血型的情况下。由于需求充足,自体输血设备市场的主要参与者提供先进且全自动的自体输血设备,以减少人工干预。例如,2021 年 4 月,LivaNova PLC 的 B-Capta 已获得美国食品药品监督管理局的批准。在复杂的儿科和成人心肺旁路手术中,该设备有助于快速准确地监测静脉和血气参数。同样,2019 年 4 月,BD 在全球推出了其 BD BACTEC 质量控制介质,以帮助在输血过程中识别受污染的血小板单位。

此外,许多公司还采取了收购、合作等战略活动来占领市场。例如,美敦力于 2019 年 10 月收购了 AV Medical Technologies。2019 年 12 月,Getinge 收购了 Applikon Biotechnology,后者是从实验室到工业规模开发和供应创新生物反应器系统的全球领导者。因此,这些进步可能会在未来几年为自体输血设备市场带来新的趋势。

 

基于应用的洞察

根据应用,自体输血设备市场细分为心脏手术、骨科手术、器官移植、创伤手术等。心脏手术部分在 2021 年占据了最大的市场份额,而器官移植部分预计在预测期内也将在市场上实现最高的复合年增长率。

自体输血设备市场参与者采用产品发布和扩张等有机战略,以扩大其全球足迹和产品组合并满足不断增长的需求。自体输血设备市场公司的发展被描述为有机和无机发展。各公司都专注于有机战略,例如产品发布和扩张。自体输血设备市场见证的无机增长战略是合作伙伴关系和协作。这些增长战略帮助自体输血设备市场参与者扩大业务并增强其地理影响力。此外,收购和合作等增长战略有助于加强他们的客户群并增加产品组合。这些公司通过多种无机战略实现了增长最大化,以提高自体输血设备的市场价值和在自体输血设备市场中的地位。有机发展占自体输血设备市场总战略发展的 66.67%。而无机战略占公司增长的 33.33%。

 

自体输血设备市场细分如下:

自体输血设备市场根据类型、应用和最终用户进行细分。根据类型,自体输血设备市场分为产品和配件。根据应用,自体输血设备市场分为心脏手术、骨科手术、器官移植、创伤手术等。

根据最终用户,自体输血设备市场分为医院、专科诊所和门诊手术中心。

 

自体输血设备市场报告范围

报告属性细节
2021 年市场规模10亿美元
2028 年市场规模13.3亿美元
全球复合年增长率(2021 - 2028)4.2%
历史数据2019-2020
预测期2022-2028
涵盖的领域按类型
  • 产品和配件
按应用
  • 心脏手术
  • 骨科手术
  • 器官移植
  • 创伤手术
  • 其他的
按最终用户
  • 医院
  • 专科诊所
  • 门诊手术中心
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 美敦力
  • 费森尤斯集团
  • 泰利福公司
  • 屋宇署
  • 齐默邦美
  • 布莱尔生物医药公司
  • 血液透析公司
  • SARSTEDT 股份公司和两合公司
  • LivaNova PLC
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

 

自体输血设备市场公司简介

 

  • 屋宇署
  • 布莱尔生物医药公司
  • 费森尤斯集团
  • 血液透析公司
  • LivaNova PLC
  • 美敦力
  • 雷达克斯公司
  • SARSTEDT 股份公司和两合公司
  • 泰利福公司
  • 齐默邦美
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the key players in the autotransfusion devices market?

The autotransfusion devices market majorly consists of the players such as Medtronic; Fresenius SE & Co. KGaA; Teleflex Incorporated; BD; Zimmer Biomet; Braile Biomedica; Haemonetics Corporation; SARSTEDT AG and Co. KG; LivaNova PLC; Redax S.p.A. among others.

What is the regional market scenario of autotransfusion devices?

Global autotransfusion devices market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for autotransfusion devices. The US is estimated to hold the largest share in the autotransfusion devices market during the forecast period. The growth of the market is attributed to factors such as increasing prevalence of cancer in the US, and cancer awareness initiatives undertaken by local governments and global health organizations. In addition, growth involvement of rare blood groups, rising number of transplant procedures and rising prevalence of chronic diseases in the region stimulate the growth of autotransfusion devices market in North America. On the other hand, need for reinfusion of blood, and advancements in healthcare facilities and infrastructure in the Asia Pacific are expected to account for the fastest growth of the region during the coming years.

Which end-user held the largest share in the autotransfusion devices market?

The ambulatory surgery centers segment dominated the global autotransfusion devices market and accounted for the largest revenue share of 30.12% in 2021.

Which application held the largest share in the autotransfusion devices market?

The organ transplantation segment dominated the global autotransfusion devices market and held the largest revenue share of 3.22% in 2021.

Which type led the autotransfusion devices market?

The accessories segment dominated the global autotransfusion devices market and held the largest revenue share of 55.66% in 2021.

Which product led the autotransfusion devices market?

The intraoperative autotransfusion systems segment dominated the global autotransfusion devices market and held the largest revenue share of 71.70% in 2021

What are the driving factors for the autotransfusion devices market across the globe?

Key factors that are driving the growth of this market are rapid increase in chronic diseases, rise in transplant, and difficulty in obtaining blood of rare groups.

What are autotransfusion devices?

The autotransfusion process involves the reinfusion of the patient's blood collected from the peritoneal cavity or thorax region. The process can be accomplished before surgery or during and after the surgery using the autotransfusion system. Medical procedures, such as joint replacement, spinal surgeries, and cardiac surgery require autotransfusion. It helps reduce the risk of infection, and abolishes the problems and complications associated with the banking and administration of homologous donor blood. It also prevents transmission of transfusion-related blood-borne diseases in patients.

The List of Companies - Autotransfusion Devices Market

  1. Medtronic
  2. Fresenius SE & Co. KGaA
  3. Teleflex Incorporated
  4. BD
  5. Zimmer Biomet
  6. Braile Biomedica
  7. Haemonetics Corporation
  8. SARSTEDT AG and Co. KG
  9. LivaNova PLC
  10. Redax S.p.A.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Device : READ MORE..